Plasma ubiquinol/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis

Clinica Chimica Acta

Volumn 253, Issue 1-2, 1996, Pages 117-126

  McDonnell, M G ^a   Archbold, G P R ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

CAPD; Diabetics; Haemodialysis; Oxidative stress; Ubiquinol

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; UBIQUINOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0030607116     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06357-7     Document Type: Article

References (28)

1. [1] Beyer RE, Nordenbrand K, Ernster L. The function of coenzyme Q in free radical production and as an antioxidant: A review. Chemica Scripta 1987;27:145-153.
2. [2] Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 1990;87:4879-4883.
3. [3] Okamoto T, Matsuya T, Fukunaga Y, Kishi T, Yamagami T. Human serum ubiquinol-10 levels and relationship to serum lipids. Internat J Vit Nutr Res 1989;59:288-292.
4. 10 within circulating lipoproteins and increased resistance to human low-density lipoprotein to the initiation of lipid peroxidation. Biochem Biophys Acta 1992;1126:247-254.
5. [5] Cabrini L, Stefanelli C, Fiorentini D, Landi L. Ubiquinol prevents α-tocopherol consumption during liposome peroxidation. Biochem Int 1991;23:743-749.
6. [6] Ernster L, Forsmark P, Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes: Relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. Biofactors 1992;3:241-248.
7. 10 - lowering effect by HMG-CoA reductase inhibitors: A double-blind, placebo-controlled study. J Clin Pharmacol 1993;33:226-229.
8. 10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Anal Med 1991;23:649-656.
9. [9] Oberley LW. Free radicals and diabetes. Free Rad Biol Med 1988;5:113-124.
10. [10] Ceriello A, Quatraro A, Guigliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diab Med 1992;9:297-299.
11. [11] Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
12. [12] Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-1650.
13. [13] Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 1986;157:106-116.
14. [14] Hatefi Y. Coenzyme Q (ubiquinone). Adv Enzymol 1963;25:275-328.
15. 10, α-tocopherol and cholesterol in biological samples by coupled-column chromatography with coulometric and ultraviolet detection. J Chromatogr 1988;425:87-97.
16. [16] Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad Biol Med 1991;10:339-352.
17. [17] Som S, Basu D, Mukherjee S, et al. Ascorbic acid metabolism in diabetes mellitus. Metab 1981;30:572-577.
18. [18] Karpen CW, Cataland S, O'Dorsio TM, Panganamala RV. Production of 12-hydroxyeicosatetraeonic acid and vitamin E status in platelets from type 1 human diabetic subjects. Diabetes 1985;34:526-531.
19. [19] Sato Y, Hotta N, Sakomoto N, Matsuoka S, Oshishi N, Yagi K. Lipid peroxide levels in serum of diabetic patients. Biochem Med 1979;21:104-107.
20. 10, alpha-tocopherol, and free cholesterol levels in sera from diabetic patients. In : Folkers K, Littarru G, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q, vol 6. Elsevier, Amsterdam, pp. 151-158.
21. [21] Lester E. The clinical value of glycated hemoglobin and glycated plasma proteins. Ann Clin Biochem 1989;26:213-219.
22. 10 in uraemic patients on chronic haemodialysis. Nephron 1994;66:153-156.
23. [23] Toborek M, Tomasz W, Drozdz M, Klin M Magner-Wrobel, Kopieczna-Grzebieniak. Effect of haemodialysis on lipid peroxidation and antioxidant systems in patients with chronic renal failure. Metabolism 1992;41(11):1229-1232.
24. [24] Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. Q J Med 1994;87:679-683.
25. [25] Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJF. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Peritoneal Dialysis Int 1992;12:252-256.
26. [26] Taccone-Gallucci M, Giardini O, Lubrano R et al. Red blood cell membrane lipid peroxidation in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 1986;6:92-95.
27. [27] Steinberg D, Parthasarathy S, Carew TF, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
28. [28] Bowry VW, Mohr D, Cleary J, Stocker R. Prevention of tocopherol - mediated peroxidation in ubiquinol - 10 - free human low density lipoprotein. J Biol Chem 1995;270:5756-5763.